Learn more

UNIV HOLY GHOST DUQUESNE

Overview
  • Total Patents
    219
  • GoodIP Patent Rank
    21,871
  • Filing trend
    ⇧ 16.0%
About

UNIV HOLY GHOST DUQUESNE has a total of 219 patent applications. It increased the IP activity by 16.0%. Its first patent ever was published in 1989. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are G D SEARLE & CO CHICAGO, SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES and 3 V BIOSCIENCES INC.

Patent filings per year

Chart showing UNIV HOLY GHOST DUQUESNEs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Gangjee Aleem 120
#2 Li Pui-Kai 29
#3 Matherly Larry H 17
#4 Selcer Kyle W 16
#5 Juola Patrick 11
#6 Murakata Chikara 8
#7 Akinaga Shiro 8
#8 Kingston Howard M 7
#9 Basu Partha 7
#10 Ryan Michael 7

Latest patents

Publication Filing date Title
WO2019173500A1 PYRAZOLO[4,3-d]PYRIMIDINES AS ANTITUMOR AGENTS
WO2019046612A1 First-in-class of shmt2 and mthfd2 inhibitors as antitumor agents
US2017050978A1 Monocyclic, thieno, pyrido, and pyrrolo pyrimidine compounds and methods of use and manufacture of the same
WO2016168637A2 Cyclopenta[d]pyrimidines and substituted cyclopenta[d]pyrimidines as antitubulin and microtubule targeting agents, monocyclic pyrimidines as tubulin inhibitors, and pyrrolopyrimidines as targeted antifolates and tubulin and multiple receptor tyrosine kinase inhibition and antitumor agents
WO2016100495A1 CONFORMATIONALLY RESTRICTED 4-SUBSTITUTED-2,6-DIMETHYLFURO[2,3-d]PYRIMIDINES AS ANTITUMOR AGENTS
WO2016022881A1 Substituted pyrimidine compounds and methods of use and manufacture
US2016039840A1 Pyrimidine compounds and pyrimido indole compounds and methods of use
CA2944510A1 Substituted bicyclic pyrimidine compounds with tubulin and multiple receptor inhibition
EP3125897A2 Substituted cyclopenta pyrimidine bicyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
WO2015127175A1 Composition, synthesis, and use of new arylsulfonyl isonitriles
WO2015127226A1 Composition, synthesis, and use of a new class of isonitriles
US2016097754A1 Mercury sensor and methods of use
US2014171396A1 Combination hormone replacement therapy (HRT) and melatonin to prevent and treat mammary cancer
US2016269589A1 Method of detecting steganographically hidden images via low-order bit comparisons
CA2889381A1 Carboxylic acid ester prodrug inhibitors of mek
WO2014011608A2 Kinetic-based tool for biometric identification, verification, validation and profiling
BR112013028521A2 authoring review system and methods for confirming authorship, for enhancing investigations with authoring technology, for preventing unauthorized email transmission, and for identifying users from computer to computer
CA2773346A1 Composition, synthesis and use of isonitriles
BR112012028415A2 method of recognition and application of trend or pattern and respective system.
US2012245168A1 Composition, synthesis, and use of new substituted pyran and pterin compounds